Gregory Anton Endress

Gregory Anton Endress

Chief Tech/Sci/R&D Officer at NeoDiagnostix, Inc.

Health Services
Health Technology
Commercial Services

Profile

Gregory Anton Endress is currently the Chief Scientific Officer at NeoDiagnostix, Inc. He previously held positions as Principal at Human Genome Sciences, Inc., Chief Scientific Officer at Protedyne Corp., Principal at Avalon Pharmaceuticals, Inc., and Principal at Life Technologies Corp.

Gregory Anton Endress active positions

CompaniesPositionStart
Chief Tech/Sci/R&D Officer 1999-12-31
All active positions of Gregory Anton Endress

Former positions of Gregory Anton Endress

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 2003-12-31
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Gregory Anton Endress's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gregory Anton Endress's experience

Connections

9

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies5

Health Services

Health Services

Health Technology

Commercial Services

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Gregory Anton Endress